Evaluate symptomatic therapy in MS: Can clinical trials be fine-tuned?

European Journal of Neurology

Volumn 18, Issue 9, 2011, Pages 1113-1114

  Solaro, Claudio ^a  

^a ASL3 genovese ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID DERIVATIVE; NABIXOMOLS; SATIVEX R; TETRAHYDROCANNABINOL DERIVATIVE; UNCLASSIFIED DRUG;

DRUG EFFICACY; DRUG TOLERABILITY; EDITORIAL; HUMAN; META ANALYSIS (TOPIC); MULTIPLE SCLEROSIS; PALLIATIVE THERAPY; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; SPASTICITY; TREATMENT OUTCOME;

FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS; MUSCLE SPASTICITY; PLANT EXTRACTS;

EID: 80051588494     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03425.x     Document Type: Editorial

References (8)

1. Rizzo MA, Hadjimichael OC, Preiningerova J, Vollmer TL. Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult Scler 2004; 10: 589-595.
2. Brichetto G, Messmer Uccelli M, Mancardi GL, Solaro C. Symptomatic medication use in multiple sclerosis. Mult Scler 2003; 9: 458-460.
3. Shakespeare DT, Boggild M, Young C. Anti-spasticity agents for multiple sclerosis (Cochrane Review). In: The Cochraine Library Issue 3, 2001.
4. Wade DT, Collin C, Stott C, Duncombe P. Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with mutliple sclerosis. Mult Scler 2010; 16: 707-714.
5. Novotna A, Mares J, Ratcliffe S, et al. A randomised, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity due to multiple sclerosis. Eur J Neurol 2011; doi: [Epub ahead of print].
6. Solaro C, Brichetto G, Battaglia MA, Messmer Uccelli M, Mancardi GL. Antiepileptic medications in multiple sclerosis: adverse effects in a three-year follow-up study. Neurol Sci 2005; 25: 307-310.
7. Quessy SN. Two-stage enriched enrolment pain trials: a brief review of designs and opportunities for broader application. Pain 2010; 148: 8-13.
8. McQuay HJ, Derry S, Moore RA, Poulain P, Legout V. Enriched enrolment with randomised withdrawal (EERW): time for a new look at clinical trial design in chronic pain. Pain 2008; 135: 217-220.